Paper Details

Paper Title

A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma.

Paper Journal Title

Clin Cancer Res

Paper Citation Count

Paper Publication Year

2022

Bio Mention

Mesh Descriptor

Author Name	Affiliation
Arun A Azad

1 - 1

Paper Details

Column Actions

Datasets